UCLA Vine Street Clinic

Los Angeles, California 90095

1 studies enrolling now · 13 studies all time

What they study most

Cocaine Use Disorder, Drug Use, HIV, HIV Infection, HIV Infections, HIV Pre-exposure Prophylaxis, HIV-1-infection, Methamphetamine Abuse, Methamphetamine Dependence, Methamphetamine-dependence, Opioid Use, Opioid-use Disorder

Studies at this site

• Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) — Running, not enrolling
• Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy — Starting soon
• Inflammation in Methamphetamine and STIs (IMSTI) — Completed
• INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit — Completed
• Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103) — Running, not enrolling
• Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2) — Completed
• HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP) — Completed
• Monthly Injectable BUP for MA Use Disorder (MURB) Trial — Stopped early
• Expression of Stress Markers During Meth Treatment (EXPRESS+) — Status unconfirmed
• Contingency Management for PrEP Adherence and/or Methamphetamine Use — Completed
• Trial of Ibudilast for Methamphetamine Dependence — Completed
• Varenicline for Methamphetamine Dependence — Completed
• Varenicline vs Placebo for the Treatment of Methamphetamine Dependence — Completed